ACTIVBIOTICS
ActivBiotics develops and sells antibiotics and combination therapies for the treatment of acute and chronic infections. The company’s lead product candidate, Rifalazil, is a proprietary, orally administered antibacterial agent which is in a Phase III clinical trial for the treatment of intermittent claudication associated with peripheral arterial disease. The company’s other product candidate, M40403, is a proprietary small molecule to mimic the function of a naturally occurring enzyme, whi... ch plays a role in various inflammatory disease states. It also develops ABI-0043 as a proprietary antibacterial agent for the treatment of complicated skin and skin structure infections caused by Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. In addition, the company identifies product candidates from its proprietary compound libraries for the treatment of inflammatory diseases and bacterial infections. The company’s superoxide dismutases (SOD) mimetic library consists of approximately 250 small molecules that mimic naturally occurring SOD enzymes.
ACTIVBIOTICS
Industry:
Health Care Medical Therapeutics
Founded:
1996-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.activbiotics.com
Total Employee:
1+
Status:
Closed
Total Funding:
17 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Amazon SSL By Default GoDaddy DNS AWS Global Accelerator OpenResty GoDaddy SSL Google Adsense AdBlock Acceptable Ads
Similar Organizations
Ablation Frontiers
A develops and markets cardiac ablation devices for the treatment of individuals suffering from atrial fibrillation.
Innovative Healthcare
Innovative Healthcare develops therapeutics for the treatment of diabetes and chronic wounds.
SoundCure
SoundCure develops and commercializes novel acoustic therapies for the treatment and suppression of tinnitus.
Investors List
Vanderbilt University
Vanderbilt University investment in Series A - ActivBiotics
Delphi Ventures
Delphi Ventures investment in Series A - ActivBiotics
HealthCare Ventures
HealthCare Ventures investment in Series A - ActivBiotics
Official Site Inspections
http://www.activbiotics.com
- Host name: a3edc0dabdef92d6d.awsglobalaccelerator.com
- IP address: 15.197.204.56
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ActivBiotics"
ActivBiotics Company Profile | Management and Employees List
ActivBiotics Profile and History. ActivBiotics is a privately held, clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel antibiotics …See details»
ACTIVBIOTICS, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACTIVBIOTICS, INC. of Wellesley, MA. Get the latest business insights from Dun & Bradstreet.See details»
ActivBiotics Company Profile 2024: Valuation, Funding ... - PitchBook
ActivBiotics General Information Description. Developer of therapies for the treatment of inflammatory diseases and bacterial infections. The company's lead product, Rifalazil, is an …See details»
ActivBiotics - Overview, News & Similar companies - ZoomInfo
ActivBiotics is a privately held, clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel antib iotics for the treatment of a wide range of …See details»
ActivBiotics Inc - Company Profile and News - Bloomberg Markets
Company profile page for ActivBiotics Inc including stock price, company news, executives, board members, and contact informationSee details»
ActivBiotics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 10, 2002: Series A - …See details»
ActivBiotics - Products, Competitors, Financials, Employees ...
PRESS RELEASE: ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates. Feb 2, 2018. Dec 19, 2007 1:21pm ActivBiotics Sells Proprietary Assets, Including Drug Product …See details»
ActivBiotics - Crunchbase
ActivBiotics develops and sells antibiotics and combination therapies for the treatment of acute and chronic infections.See details»
ActivBiotics Pharma LLC - Drug pipelines, Patents, Clinical trials ...
Explore ActivBiotics Pharma LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 1 literature, Drug:Rifalazil. ... The statistics for drugs in the Pipeline is the …See details»
Metaphore Pharmaceuticals, Inc. And ActivBiotics Sign ... - BioSpace
Dec 14, 2005 ActivBiotics, Inc. is a private biopharmaceutical company located in Lexington, MA, focused on the discovery, development and commercialization of breakthrough …See details»
ActivBiotics Inc. - BioCentury Company Profiles - BCIQ
Sep 19, 2011 ActivBiotics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Organization | MetaPhore Pharmaceuticals
Status: Acquired by ActivBiotics Pharma (2006) ... Organization Overview. First Clinical Trial. 2001 NCT00033956. First Marketed Drug. None First NDA Approval. None Last Known …See details»
ActivBiotics Appoints Steven C. Gilman Chairman and CEO
May 1, 2007 ActivBiotics, Inc. is a private biopharmaceutical company located in Lexington, Massachusetts, that is focused on the development and commercialization of novel therapies …See details»
ActivBiotics - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ActivBiotics develops and sells antibiotics and combination therapies for the treatment of acute and chronic infections.See details»
Press Release: ActivBiotics Appoints Steven C. Gilman Chairman …
May 1, 2007 Trending T. Biotech. Cell & Gene Therapy; Clinical Data; Venture CapitalSee details»
ActivBiotics going into liquidation after trial failure
Dec 19, 2007 ActivBiotics was founded 11 years ago as Merlin Technologies. - see the release for more - read the report from MassHighTech. Related Article: ActivBiotics, Metaphore sign …See details»
ActivBiotics, Metaphore sign merger agreement | Fierce Biotech
Dec 13, 2005 ActivBiotics and Metaphore Pharmaceuticals have announced a merger agreement. The merger, set to close by the end of December or early January, would make …See details»
PRESS RELEASE: ActivBiotics Sells Proprietary Assets, Including …
Dec 19, 2007 ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates. LEXINGTON, MA, December 18, 2007 -- ActivBiotics, Inc. today announced that following a …See details»
Research programme: antibacterials - ActivBiotics - AdisInsight
ActivBiotics is developing new small molecule antibiotics for the treatment of infectious diseases. ABI 0043 is the lead preclinical candidate and has Research programme: antibacterials - …See details»